ReviewCancers2025

The Role of Neoadjuvant Immunotherapy in the Management of High-Risk Stage III Resectable Melanoma: A Literature Review.

Jobran Mansour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.